Explaining intermediate filament accumulation in giant axonal neuropathy

References

• Mahammad S, Murthy SN, Didonna A, Grin B, Israeli E, Perrot R, et al. Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation. J Clin Invest 2013; 123:1964 - 75; http://dx.doi.org/10.1172/JCI66387; PMID: 23585478
   PubMed Web of Science ®Google Scholar
• Yang Y, Allen E, Ding J, Wang W. Giant axonal neuropathy. Cell Mol Life Sci 2007; 64:601 - 9; http://dx.doi.org/10.1007/s00018-007-6396-4; PMID: 17256086
   PubMed Web of Science ®Google Scholar
• Bomont P, Cavalier L, Blondeau F, Ben Hamida C, Belal S, Tazir M, et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 2000; 26:370 - 4; http://dx.doi.org/10.1038/81701; PMID: 11062483
   PubMed Web of Science ®Google Scholar
• Berg BO, Rosenberg SH, Asbury AK. Giant axonal neuropathy. Pediatrics 1972; 49:894 - 9; PMID: 4339350
   PubMed Web of Science ®Google Scholar
• Carpenter S, Karpati G, Andermann F, Gold R. Giant axonal neuropathy. A clinically and morphologically distinct neurological disease. Arch Neurol 1974; 31:312 - 6; http://dx.doi.org/10.1001/archneur.1974.00490410060005; PMID: 4153361
   PubMed Web of Science ®Google Scholar
• Eriksson JE, Dechat T, Grin B, Helfand B, Mendez M, Pallari HM, et al. Introducing intermediate filaments: from discovery to disease. J Clin Invest 2009; 119:1763 - 71; http://dx.doi.org/10.1172/JCI38339; PMID: 19587451
   PubMed Web of Science ®Google Scholar
• Peiffer J, Schlote W, Bischoff A, Boltshauser E, Müller G. Generalized giant axonal neuropathy: a filament-forming disease of neuronal, endothelial, glial, and schwann cells in a patient without kinky hair. Acta Neuropathol 1977; 40:213 - 8; http://dx.doi.org/10.1007/BF00691956; PMID: 602684
   PubMed Web of Science ®Google Scholar
• Treiber-Held S, Budjarjo-Welim H, Reimann D, Richter J, Kretzschmar HA, Hanefeld F. Giant axonal neuropathy: a generalized disorder of intermediate filaments with longitudinal grooves in the hair. Neuropediatrics 1994; 25:89 - 93; http://dx.doi.org/10.1055/s-2008-1071592; PMID: 8072681
   PubMed Web of Science ®Google Scholar
• Bomont P, Koenig M. Intermediate filament aggregation in fibroblasts of giant axonal neuropathy patients is aggravated in non dividing cells and by microtubule destabilization. Hum Mol Genet 2003; 12:813 - 22; http://dx.doi.org/10.1093/hmg/ddg092; PMID: 12668605
   PubMed Web of Science ®Google Scholar
• Cleveland DW, Yamanaka K, Bomont P. Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway. Hum Mol Genet 2009; 18:1384 - 94; http://dx.doi.org/10.1093/hmg/ddp044; PMID: 19168853
   PubMed Web of Science ®Google Scholar
• Klymkowsky MW, Plummer DJ. Giant axonal neuropathy: a conditional mutation affecting cytoskeletal organization. J Cell Biol 1985; 100:245 - 50; http://dx.doi.org/10.1083/jcb.100.1.245; PMID: 3880753
   PubMed Web of Science ®Google Scholar
• Leung CL, Pang Y, Shu C, Goryunov D, Liem RK. Alterations in lipid metabolism gene expression and abnormal lipid accumulation in fibroblast explants from giant axonal neuropathy patients. BMC Genet 2007; 8:6; http://dx.doi.org/10.1186/1471-2156-8-6; PMID: 17331252
   PubMed Web of Science ®Google Scholar
• Pena SD. Giant axonal neuropathy: intermediate filament aggregates in cultured skin fibroblasts. Neurology 1981; 31:1470 - 3; http://dx.doi.org/10.1212/WNL.31.11.1470; PMID: 6273766
   PubMed Web of Science ®Google Scholar
• Pena SD, Opas M, Turksen K, Kalnins VI, Carpenter S. Immunocytochemical studies of intermediate filament aggregates and their relationship to microtubules in cultured skin fibroblasts from patients with giant axonal neuropathy. Eur J Cell Biol 1983; 31:227 - 34; PMID: 6315439
   PubMed Web of Science ®Google Scholar
• Dequen F, Bomont P, Gowing G, Cleveland DW, Julien JP. Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1. J Neurochem 2008; 107:253 - 64; http://dx.doi.org/10.1111/j.1471-4159.2008.05601.x; PMID: 18680552
   PubMed Web of Science ®Google Scholar
• Ganay T, Boizot A, Burrer R, Chauvin JP, Bomont P. Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice. Mol Neurodegener 2011; 6:25; http://dx.doi.org/10.1186/1750-1326-6-25; PMID: 21486449
   PubMed Web of Science ®Google Scholar
• Mussche S, Devreese B, Nagabhushan Kalburgi S, Bachaboina L, Fox JC, Shih HJ, et al. Restoration of cytoskeleton homeostasis after gigaxonin gene transfer for giant axonal neuropathy. Hum Gene Ther 2013; 24:209 - 19; http://dx.doi.org/10.1089/hum.2012.107; PMID: 23316953
   PubMed Web of Science ®Google Scholar
• Xu L, Wei Y, Reboul J, Vaglio P, Shin TH, Vidal M, et al. BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 2003; 425:316 - 21; http://dx.doi.org/10.1038/nature01985; PMID: 13679922
   PubMed Web of Science ®Google Scholar
• Perez-Torrado R, Yamada D, Defossez PA. Born to bind: the BTB protein-protein interaction domain. Bioessays 2006; 28:1194 - 202; http://dx.doi.org/10.1002/bies.20500; PMID: 17120193
   PubMed Web of Science ®Google Scholar
• Furukawa M, He YJ, Borchers C, Xiong Y. Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat Cell Biol 2003; 5:1001 - 7; http://dx.doi.org/10.1038/ncb1056; PMID: 14528312
   PubMed Web of Science ®Google Scholar
• Pintard L, Willems A, Peter M. Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family. EMBO J 2004; 23:1681 - 7; http://dx.doi.org/10.1038/sj.emboj.7600186; PMID: 15071497
   PubMed Web of Science ®Google Scholar
• Gonzalez SL, Stremlau M, He X, Basile JR, Münger K. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J Virol 2001; 75:7583 - 91; http://dx.doi.org/10.1128/JVI.75.16.7583-7591.2001; PMID: 11462030
   PubMed Web of Science ®Google Scholar
• Berezutskaya E, Bagchi S. The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome. J Biol Chem 1997; 272:30135 - 40; http://dx.doi.org/10.1074/jbc.272.48.30135; PMID: 9374493
   PubMed Web of Science ®Google Scholar
• Denk H, Stumptner C, Zatloukal K. Mallory bodies revisited. J Hepatol 2000; 32:689 - 702; http://dx.doi.org/10.1016/S0168-8278(00)80233-0; PMID: 10782920
   PubMed Web of Science ®Google Scholar
• Li R, Messing A, Goldman JE, Brenner M. GFAP mutations in Alexander disease. Int J Dev Neurosci 2002; 20:259 - 68; http://dx.doi.org/10.1016/S0736-5748(02)00019-9; PMID: 12175861
   PubMed Web of Science ®Google Scholar
• Rudrabhatla P, Jaffe H, Pant HC. Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer’s NFTs. FASEB J 2011; 25:3896 - 905; http://dx.doi.org/10.1096/fj.11-181297; PMID: 21828286
   PubMed Web of Science ®Google Scholar
• Liu Q, Xie F, Siedlak SL, Nunomura A, Honda K, Moreira PI, et al. Neurofilament proteins in neurodegenerative diseases. Cell Mol Life Sci 2004; 61:3057 - 75; http://dx.doi.org/10.1007/s00018-004-4268-8; PMID: 15583867
   PubMed Web of Science ®Google Scholar